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Abstract
Background: In an effort to identify previously unrecognized aspects of editorial decision-making,
we explored the words and phrases that one group of editors used during their meetings.
Methods: We performed an observational study of discussions at manuscript meetings at JAMA, a
major US general medical journal. One of us (KD) attended 12 editorial meetings in 2003 as a
visitor and took notes recording phrases from discussion surrounding 102 manuscripts. In addition,
editors attending the meetings completed a form for each manuscript considered, listing the
reasons they were inclined to proceed to the next step in publication and reasons they were not
(DR attended 4/12 meetings). We entered the spoken and written phrases into NVivo 2.0. We
then developed a schema for classifying the editors' phrases, using an iterative approach.
Results: Our classification schema has three main themes: science, journalism, and writing. We
considered 2,463 phrases, of which 87 related mainly to the manuscript topic and were not
classified (total 2,376 classified). Phrases related to science predominated (1,274 or 54%). The
editors, most of whom were physicians, also placed major weight on goals important to JAMA's
mission (journalism goals) such as importance to medicine, strategic emphasis for the journal,
interest to the readership, and results (729 or 31% of phrases). About 16% (n = 373) of the phrases
used related to writing issues, such as clarity and responses to the referees' comments.
Conclusion: Classification of editorial discourse provides insight into editorial decision making
and concepts that need exploration in future studies.
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Background
No public knowledge is gained from scientific and bio-
medical research unless the study methods and results are
properly written up and disseminated, typically by publi-
cation in a widely available journal. The decision to pub-
lish study findings involves many individuals and groups,
including the investigators, the designated authors, the
peer reviewers, the journal editors, and editor-in-chief.
Some parts of the decision-making process are more easily
studied than others, in part because traditionally, publish-
ing decisions have been confidential. From substantial
existing research, we know that investigators, not journal
editors, are the ones mainly responsible for the decision
to publish, and that this decision is related to the direction
and strength of study findings (publication bias) [1-6].
There are many fewer studies of the editorial decision-
making process [7-10]. Editors cannot discuss or make
decisions about manuscripts they never receive. A 2002
study of editorial decision-making at the US general med-
ical journal JAMA found that editors favor high quality
science, and any bias against negative results is either
small or does not exist [7]. Studies of editorial decision-
making have mainly addressed issues of bias, but not
other factors related to journal mission, responsibility,
and financial health. For example, one might ask whether
editors are interested in publishing "newsworthy" results:
those that are completely unexpected, that confirm a long
held belief, or that settle a controversy once and for all.
One might also be interested in whether a single set of
rules could be devised to describe acceptance decisions.
Editors may one week reject a report because it is similar
to another one recently published, but may the next week
accept a paper because it is similar to a recent contribution
in their journal.
JAMA, a major, weekly, general medical journal in the
United States, has a broad mission and low acceptance
rate. We decided to attend journal editorial decision-mak-
ing meetings to learn more about what was discussed, to
allow construction of quantitative survey instruments that
would capture a richer picture of factors influencing pub-
lication decisions. The discussions we listened to relate
particularly to understanding the mechanisms used when
editors must choose only 5% to 10% from a large pool of
submitted manuscripts.
In an effort to identify previously unrecognized aspects of
editorial decision-making, we explored the words and
phrases that one group of editors used during their meet-
ings. We did not use formal qualitative methods to ana-
lyze the information collected, rather our goal was to help
to generate hypotheses for those doing research on edito-
rial decision making and publication practices.
Methods
In 2003, 5064 manuscripts (not including letters) were
submitted to JAMA. These were distributed to the editors,
almost all physicians, who reject at least half outright
without obtaining comments from peer reviewers. When
manuscripts are returned from peer reviewers, typically
two or three, editors can reject directly or bring the manu-
script to an editorial meeting. Some editors bring most of
their papers to the table for a decision and others bring
only papers they feel have a very good chance of accept-
ance. Because manuscripts are assigned to a single editor
for review, only one editor has typically read a manuscript
before the meeting. In 2003, approximately 940 manu-
scripts were brought to the meeting for discussion. All dis-
cussions at the meetings are kept in strict confidence, by
JAMA's standing rules.
One of us (KD) attended 12 twice weekly editorial meet-
ings, as a visitor, at the JAMA offices in Chicago, Illinois,
USA in January and February 2003 (some meetings were
missed by KD because of scheduling conflicts), and took
notes on the discussion surrounding 102 manuscripts
(two related manuscripts were discussed as one, and so we
counted them as a single manuscript). Her notes were not
verbatim transcripts of the meeting's discussions. The
meeting attendees varied somewhat from meeting to
meeting, but typically comprised about eight in-house
editors, including editors with content, managing, and
statistical responsibilities, and the Editor-in-Chief. Other
editors (including DR who attended 2 of the 12 meetings
in person, and 2 by phone) attended by teleconference if
a manuscript for which they were responsible was being
discussed. Editors volunteered one-by-one, but in no par-
ticular order, to discuss the manuscripts for which they
were responsible. Anecdotal reports from editors attend-
ing the manuscript meetings is that the meetings attended
as part of this study were representative of other meetings.
The discussion of each manuscript began with a descrip-
tion of the paper topic and study characteristics, with
details added as necessary. The presentation progressed to
comments made by the peer reviewers. The vast majority
of presented manuscripts had completed at least one
round of peer review.
The note-taker (KD) recorded words and phrases spoken
by the editors in the context of each manuscript discussed,
the time each discussion took, and the comments and
publication recommendation of each of the peer review-
ers. In addition, at the end of discussion about each man-
uscript, editors attending the meeting completed a form
on which they listed the reasons they were "inclined to
proceed to the next step towards review and/or accept-
ance" and reasons they were not. The editors were askedBMC Medical Research Methodology 2007, 7:44 http://www.biomedcentral.com/1471-2288/7/44
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not to record their names on these forms. Forms were not
collected at meetings KD did not attend.
ES and CM extracted the phrases from KD's notes and
from the completed forms and entered them into NVivo
2.0 qualitative analysis software (Qualitative Solutions
and Research Pty. Ltd, Australia). Each manuscript was
considered a separate document with an array of
attributes such as date of discussion, number of positive
and negative reviews by outside peer reviewers, time taken
for discussion, its categorization by the editors as describ-
ing research or not, and final disposition of the manu-
script.
We next used an iterative process to develop a classifica-
tion schema for the 2,463 spoken and written phrases. We
considered several possible themes, including the JAMA
objectives [see Table 1], general journalistic goals, and ad
hoc schema suggested by the phrases recorded.
For the first draft of the schema, CM and KD reviewed the
phrases and documents from the editors' discussions and
assigned them to 20 categories related to medical editorial
decision-making and publication bias (as defined above).
This schema was reviewed by two independent epidemi-
ologists. Each performed an independent review followed
by a group discussion with KD. We modified the schema
further, categorizing phrases by whether they were related
to science (eg, likelihood of bias relating to the study
design), editorial beliefs or values (eg, likely interpreta-
tion by the public), or manuscript features (eg, short, well
written). Using Nvivo, CM re-sorted most of the 20 cate-
gories into the new schema, retiring some categories and
merging others. In a one hour meeting, CM and KD pre-
sented the revised schema to two independent social sci-
entists, who suggested additional refinements.
Finally, we revised the concept of editorial beliefs and val-
ues to encompass what we called general journalistic
goals, and developed a separate construct within the
schema. We considered journalism in medicine to encom-
pass a broad mission that includes educational, public
health, and strategic goals such as timeliness, serving the
readers' interests, presenting important medical issues,
and addressing controversies. In the present instance,
"journalism goals" were those that spoke to the mission of
JAMA and other medical journals – meaning factors and
values important to medical (or clinical) journals that
publish new research (such as importance to medicine,
strategic emphasis for the journal, and interest to the read-
ership).
Thus, we classified each phrase as belonging to one of
three mutually exclusive categories: science, journalism,
and writing. Each phrase was further classified using a
subcode within each category and each phrase was
assigned a single code. All categories include phrases that
are both favorable and unfavorable, although we describe
the category using mainly positive terms [see Table 2]. For
instance, phrases used to note exemplary ethical proc-
esses, as well as phrases used to note suspected conflict of
interest, were classified as part of the "Ethics/Conflict of
Interest" category.
We exported 2,463 coded phrases into Excel 2003 (Micro-
soft Corp) for counts. We excluded 87 phrases (76 of
which were spoken) that were coded as describing the title
or topic of the manuscript, leaving 2376 coded phrases for
analysis.
Table 1: JAMA's Key and Critical Objectives
Key Objective
To promote the science and art of medicine and the betterment of the public health
Critical Objectives
1. To maintain the highest standards of editorial integrity independent of any special interests
2. To publish original, important, well-documented, peer-reviewed articles on a diverse range of medical topics
3. To provide physicians with continuing education in basic and clinical science to support informed clinical decisions
4. To enable physicians to remain informed in multiple areas of medicine, including developments in fields other than their own
5. To improve health and health care internationally by elevating the quality of medical care, disease prevention, and research
6. To foster responsible and balanced debate on issues that affect medicine and health care
7. To anticipate important issues and trends in medicine and health care
8. To inform readers about nonclinical aspects of medicine and public health, including the political, philosophic, ethical, legal, environmental, 
economic, historical, and cultural
9. To recognize that, in addition to these specific objectives, THE JOURNAL has a social responsibility to improve the total human condition and 
to promote the integrity of science
10. To achieve the highest level of ethical medical journalism and to produce a publication that is timely, credible, and enjoyable to readBMC Medical Research Methodology 2007, 7:44 http://www.biomedcentral.com/1471-2288/7/44
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Table 2: Classification Schema for 2376 Written and Spoken Phrases
A. Science (1274 phrases)
1. Research Design and Methods (481 
phrases)
Aspects of the quality of the description of the design and methods as well as the methods 
themselves, from the hypothesis, to assumptions, to bias, to outcomes defined. Also 
includes some factual statements, such as the type of study design used.
2. Presentation and Interpretation of 
Results (250 phrases)
Concern about message, tone, context, scholarship, rationale for conclusions drawn, 
whether conclusions match study strength, adequacy of references, preliminary or early 
results, need for additional discussion.
3. Analysis (157 phrases) Analysis is appropriate, inappropriate, incorrect, incomplete, not clear; rates and measures 
used. Adjustment for confounders and effect modifiers, issues related to subgroup analysis, 
intention to treat analysis.
4. Population Studied (97 phrases) Concerns about the population or database and why it was chosen, more information 
about population needed, potential for selection bias, response rate.
5. Power, Sample Size (66 phrases) Any comment about power, size of study sample or the dataset.
6. Measures Used (70 phrases) Methods specifically concerning measures used and whether they are reliable, valid, are 
expressed correctly, are sufficient.
7. More Information/Data Needed (60 
phrases)
Comments that data or details about data are needed, including full CONSORT data.
8. Generalizable information/results (37 
phrases)
Potential application of information beyond study population, representativeness of 
broader patient population.
9. Quality of the Data (31 phrases) Concerns about data quality, validity of data, completeness.
10. Conflict of Interest/Ethics (25 phrases) Concerns about financial and other conflicts of interest, as well as concerns about study 
ethics.
B. Journalism (729 phrases)
1. Important for Medicine (131 phrases) Any statement that the study, results, topic, disease, message are important, of interest, or 
common.
2. Strategic Advantage to Publish (126 
phrases)
Reasons why it may be good to publish this paper or not (eg, published elsewhere, previous 
or current JAMA similar or related publication, need more like this). Specific mention of 
JAMA (except readership) or related to JAMA mission. Specialized paper (as opposed to 
specialized audience), should be sent to Archives. Possible editorial.
3. Interesting results or topic (95 phrases) Any phrase with "interesting" or similar word in it (eg, interesting topic, analysis, 
hypothesis), except "readers would find interesting". Includes comments relating to a low 
likelihood of publication leading to behavior change, or the fact that the paper doesn't add 
anything. Also includes fascinating, boring, good, excellent, great, relevant.
4. Results (topic) (76 phrases) Any statement describing the study outcomes and results.
5. Author repute (71 phrases) References to the author prominence or characteristics of the author (including where 
from, good group, published previously in JAMA), author role in paper.
6. Positive or negative results (48 phrases) Concerns positive, negative or null results or findings of study, statistical significance, 
beneficial outcomes, positive, negative, modest association, clinically significant, effective 
intervention, size of association, and effect size.
7. Novel, new (47 phrases) Manuscript contains novel information, findings, data, is a novel study, uses novel methods. 
New information, unique data, innovation in some aspect of study, new methods, cool new 
technology, unique work, few similar studies.
8. Readership (29 phrases) Potential readership interest or lack of it, our readers would find it interesting, potential 
audience beyond medical community, public health interest, policy and government issues, 
correlation with current events.
9. Knowledge Gap (27 phrases) More information needed in this area.
10. Timeliness (24 phrases) "Hot" or timely topic, topical, big stuff, causes excitement, enormous public health, political 
interest, pressing issue, increasingly discussed, emerging treatment or drug, problem, 
increasing disease incidence.
11. Refutes-Confirms Standard Practice/
Thinking (23 phrases)
Results that refute or confirm standard thinking or practice. Provides new information 
about clinical problem.
12. Policy, message and public response (20 
phrases)
Public and private sector response to the topic or findings, possible consequences of 
publication, including policy implications. Manuscript from government or policy makers.
13. Special Study Characteristics (12 phrases) A characteristic of the study that sets it apart from other studies.
C. Writing (373 phrases)
1. Peer Review (282 phrases) Any comment about revisions needed, peer reviewer comments received, editor's own 
tendency to accept or reject. When a specific change is requested (eg, "still fuzzy about 
search strategy"), code with science or journalism, as appropriate.
2. Writing (91 phrases) Relates to presentation only, not clarity of description of study methods.
All categories include positive and negative phrases. For the most part, phrases used here are descriptive and do not reflect exact oral or written 
statements.BMC Medical Research Methodology 2007, 7:44 http://www.biomedcentral.com/1471-2288/7/44
Page 5 of 7
(page number not for citation purposes)
Because our goal was to develop new ways to assess man-
uscript decision-making and publication bias, and
because it could in no way influence the fate of manu-
scripts being discussed, our project did not involve written
informed consent. Editors received written material
describing the project, and the project was thoroughly dis-
cussed, at the initial manuscript meeting before note-tak-
ing and form completion began. We consulted officials at
the Johns Hopkins Bloomberg School of Public Health
Committee on Human Research who requested that we
not include identifying information about the editors,
peer reviewers, or authors.
Results
Our results include 2,376 phases, 1,773 spoken and 603
written, which we present combined unless otherwise
noted. Spoken phrases include 459 referring specifically
to comments made by the peer reviewers and 1,314 that
reflect the editors' own comments.
The most frequent phrases used concerned scientific
issues (1,274 phrases), including research design and
methods, presentation and interpretation of results, anal-
ysis methods, population studied, power and sample size,
measurement variables and measures used, the need for
additional data, generalizability, quality of the data, and
conflict of interest/ethics [see Table 2]. Phrases associated
with journalistic concerns (n= 729) included those classi-
fied as referring to some aspect of the manuscript as
important to medicine, associated with a strategic empha-
sis for the journal, an interesting topic or results, a state-
ment describing the study findings, relating to the author,
a study's positive or negative results, novel/new content,
readership concerns, filling a knowledge gap, timeliness,
refuting or confirming standard practice or thinking, a
topic relating to policy issues/a public message/public
response, and special study characteristics. Finally,
phrases we classified as concerned with writing (n = 373)
were coded as either related directly to writing (eg, "not
clear", "dense", "needs a rewrite"), or indirectly, when
they referred to the refereeing process but not a specific
referee comment that could be otherwise classified (eg, "a
very thoughtful review", "authors responsive", "good revi-
sions," "positive reviews").
When we examined the 603 written comments made by
the editors following each manuscript discussion, we
found that science, journalism, and writing were all
important factors in the editors' opinions, regarding
whether to proceed with acceptance or not [see Table 3].
Research design and methods (science) phrases were used
most often, with importance to medicine (journalism),
and comments related to the refereeing process (writing)
next. The rankings of written comments were not mean-
ingfully affected when we examined research articles only
or accepted articles only.
Discussion
Our goal was to identify new aspects of editorial decision-
making that can be used to guide research on publication
bias, particularly relating to the stage of the process where
editors physically meet around a table and by teleconfer-
ence to discuss the merits of the manuscripts presented to
the group. We found that the discourse at manuscript
meetings could be recorded and analyzed, using two
means of word and phrase collection. One method was
simple note-taking at the meeting, which, by its nature, is
likely to be incomplete, for example because the note-
Table 3: Coded Reasons to Proceed and Not to Proceed with Publication, as Noted by Editors in Phrases on Written Forms 
Completed for Each Manuscript
Phrase code Classification Number of phrases written
Research design & methods Science 144 (23.9)
Important to medicine Journalism 59 (9.8)
Peer review comments Writing 51 (8.4)
Analysis Science 49 (8.1)
Presentation & interpretation of results Science 46 (7.6)
Interesting results or topic Journalism 42 (7.0)
Power, sample size Science 26 (4.3)
Population studied Science 25 (4.1)
More data needed Science 19 (3.2)
Measures used Science 17 (3.0)
Writing Writing 15 (2.5)
Novel/new Journalism 14 (2.3)
Positive or negative results Journalism 12 (2.2)
Quality of the data Science 11 (2.0)
Other reasons Science, journalism, writing 73 (12.1)
Total written phrases -- 603 (100)BMC Medical Research Methodology 2007, 7:44 http://www.biomedcentral.com/1471-2288/7/44
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taker did not hear or did not record all comments. The
other method was a collection of a paper form on which
editors were asked to list the reasons they were inclined to
proceed to the next step in publication and reasons they
were not. Neither of these methods uses standard qualita-
tive research methodology, but instead combines qualita-
tive and epidemiologic approaches. As far as we know,
this methodology has not been employed before.
We developed our classification schema iteratively, with
full knowledge of the phrases recorded. While our classi-
fication schema is only one of many possible perspectives,
with overlapping categories, and the coding of individual
phrases is subjective, our goal was to group editorial com-
mentary in a way that would help future researchers to
study the editorial process, rather than to identify "the
truth".
By identifying the major topics of editorial discussion, our
work contributes also to development of new variables for
studying the publication process more generally. While a
body of literature exists on factors involved in editorial
decision making, the hypotheses tested in past studies (eg,
whether publication is associated with statistical signifi-
cance of results) have mainly reflected individual authors'
opinions and experience regarding the decision-making
process, and anecdotal rather than recorded evidence.
We did not collect any data on the manuscripts rejected
before this stage, and cannot infer anything about the
process leading to rejection. It is possible for example, that
some reasons for rejection are not reflected in the discus-
sion of manuscripts considered at the manuscript meet-
ings.
Most of the discussion around the table at the 12 JAMA
manuscript meetings concerned the science of research
presented in the manuscripts. This corresponds indirectly
to the findings of Olson and colleagues who found an
association between acceptance for publication and fac-
tors positively associated with study quality, for reports of
clinical trials submitted to JAMA [7].
Perhaps more interesting is the discussion related to what
we categorized as "journalism" concerns. This included
phrases conveying the concept that the topic or findings
were "important," as well as related phrases such as "inter-
esting" and those associated with the study findings.
While there is nothing surprising about medical journal
editors being attracted to important or interesting reports,
nor about physician-editors attaching degrees of impor-
tance to studies likely to affect the care of patients, we now
are able to see the context in which study results are dis-
cussed. We would expect, and indeed found, that com-
ments in this category were less frequent than those
related to science, given that if the science is shaky there
would be little point in much further discussion.
A second aspect of the journalism category involved the
editors' interest in maximizing strategic advantage for the
journal and related readership issues. Phrases classified in
the "strategic emphasis" category included "refer to
Archives", "published elsewhere", "we want the whole
thing, not just a salami slice", "similar paper in revision",
"not for JAMA", "too long", "too specialized". Examina-
tion of the statement of JAMA's aims reveals extensive lan-
guage indicating that such journalistic features of articles
are valued. It is understandable that biomedical editors
choose manuscripts that match the stated mission of a
journal, which includes an embedded code of values and
beliefs. No matter what the intention, those beliefs are a
"differential inclination," and may contribute to publica-
tion bias, broadly defined. In addition, publishing is a
business with profit-making goals, which can indirectly
influence a journal's scope and selection of manuscripts
[11], for example selection of articles likely to be fre-
quently cited and thus positively influence the impact fac-
tor.
Written summaries of reasons to proceed to the next stage
toward acceptance or not, completed for each manuscript
by the editors, reflected the combined importance of sci-
ence, journalism, and writing considerations. Peer
reviewer comments ranked high in reasons given by edi-
tors to proceed toward acceptance or not. Given that the
manuscripts discussed at meetings are those still under
consideration after two elimination rounds, and that refe-
rees are not necessarily experts and can sometimes be
wrong, the continuing influence of peer reviewers is espe-
cially important. Our meeting notes also indicate a major
role for peer review in editorial decision-making, with
more than 25% (459/1773) of the spoken phrases refer-
ring to comments by the reviewers.
In the future, it would be useful to examine whether
accepted and rejected manuscripts differ in the discussion
content and written summaries. It would also be interest-
ing to see whether similar proportions of peer reviewer
comments mentioned in the discussions were positive
and negative. Finally, it would be useful to compare the
comments attributed to the peer reviewers with phrases
used by the editors, to see if their comments reflect similar
concerns.
This project provides insight into the process at one jour-
nal, focusing specifically on comments leading to requests
for manuscript revision, acceptance, or rejection. This
journal was selected because it has a tradition of willing-
ness to participate in research about the peer review proc-
ess [7]. Although we do not know whether the process atPublish with BioMed Central    and   every 
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JAMA is generalizable to other journals, expansion of our
thinking in this area will inform future research, which
was our goal.
Conclusion
We developed a classification of editorial discourse that
provides insight into editorial decision-making and con-
cepts that need exploration in future studies.
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